722550-01-8

Basic information

• Product Name: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)
• Synonyms: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI);2-Amino-4-pyrrolidinopyridine;2-Amino-4-(pyrrolidin-1-yl)pyridine;4-(Pyrrolidin-1-yl)pyridin-2-amine, 1-(2-Aminopyridin-4-yl)pyrrolidine;4-(1-pyrrolidinyl)-2-Pyridinamine
• CAS NO: 722550-01-8
• Molecular Formula: C₉H₁₃N₃
• Molecular Weight: 163.223
• Product Categories: AMINETERTIARY
• Mol File: 722550-01-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 353.005°C at 760 mmHg
• Flash Point: 167.292°C
• Appearance: /
• Density: 1.17g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.617
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(722550-01-8)
• EPA Substance Registry System: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(722550-01-8)

Safety Data

• Hazardous Substances Data: 722550-01-8(Hazardous Substances Data)

Usage

General Description

2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI) is a chemical compound with the molecular formula C11H15N3. It is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. This chemical is known for its aromatic properties and is primarily used in the production of drugs for various medical purposes. It is an important building block in chemical reactions and is commonly used in research and development of new drugs. The compound is classified as a pyridine and has a pyrrolidine ring, making it a versatile compound for various chemical reactions and applications.

InChI:InChI=1/C9H13N3/c10-9-7-8(3-4-11-9)12-5-1-2-6-12/h3-4,7H,1-2,5-6H2,(H2,10,11)

Upstream product

• 123-75-1 pyrrolidine 
• 19798-80-2 2-Amino-4-chloropyridine 

Relevant articles and documents

Synthesis of 2,5-thiazole butanoic acids as potent and selective αvβ3 integrin receptor antagonists with improved oral pharmacokinetic properties

We describe a series of 2,5 thiazole containing compounds, which are potent antagonists of the integrin αvβ3 and show selectivity relative to the other integrins, such as αIIbβ 3 and αvβ6. These analogs were demonstrated to have high bioavailability relative to other relative heterocyclic analogs.

THIAZOLE COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES

The present invention relates to pharmaceutical compositions comprising compounds of the Formula (I), and methods of selectively inhibiting or antagonizing the ανβ3 and/or the ανβ5 integrin without significantly inhibiting the ανβ6 integrin.